ABSTRACT Adult bovine aortic tissue was treated with 6 M guanidinium chloride in the presence of proteinase inhibitors to obtain an extract that was essentially devoid of collagenous components and appeared homogeneous by electron microscopy. When this extract was dispersed by sonication it was found to be a very potent inducer of human platelet aggregation. This interaction required the presence of von Willebrand factor and of its receptor (glycoprotein Ib) on platelet membrane. This was demonstrated by the fact that the aggregation ofnormal blood platelets resuspended in plasmas deficient in von Willebrand factor was significantly diminished as compared to aggregation in control plasma. Moreover, this aggregation was inhibited by a monoclonal antibody, IgG AN51, to platelet glycoprotein Ib. These studies provide direct biochemical evidence for the existence of a thrombogenic constituent of the vessel wall that is noncollagenous and von Willebrand factor-dependent.
Arterial thrombosis and hemostasis are initiated by the adhesion ofblood platelets to certain macromolecules ofthe subendothehum. A morphological and histochemical study ofaortae treated with purified enzymes and exposed to blood flow under the conditions described by Baumgartner and Haudenschild (1) has demonstrated that, in addition to collagen, the microfibrillar component of elastic fibers may represent a second thrombogenic structure in the vessel wall (2) . Supporting biochemical evidence has been sought in this study by analysis of extracts ofaortic tissue capable ofpromoting a reaction with blood plate-, lets. An extract ofbovine aorta obtained under denaturing conditions known to release "microfibril-related glycoproteins" from elastic fibers of bovine ligamentum nuchae (3, 4) was obtained and partially characterized. with respect to its protein and glycoprotein contents and overall amino acid composition. This extract was tested for its ability to induce platelet aggregation in conditions applied to a "microfibrillar extract" ofplacenta that was found able to aggregate platelets with possible involvement of platelet glycoprotein Ib, as suggested by the role of plasma von Willebrand factor (vWF) (5) and by the inhibitory effect of a monoclonal antibody (IgG AN51) to human platelet glycoprotein Ib. Thus, microfibrillar material present in connective tissues was characterized as able to induce platelet aggregation in a process dependent on the presence of vWF.
MATERIALS AND METHODS Microfibrillar Material. Adult bovine aortae obtained from Manchester Abbatoirs were freed ofadventitial tissue and were finely diced into pieces of 1-2 mm3. Exhaustive extraction of the tissue with 0.02 M phosphate buffer (pH 7.4) containing 0.05 M NaCl, 0.1 M e-aminocaproic acid, 2 mM EDTA, 2 mM N-ethylmaleimide, 0.05 mM phenylmethylsulfonyl fluoride, and 1% NaN3 yielded a saline extract. The residue then was extracted twice with 10 vol of 50 mM Tris'HCl buffer (pH 7.4) containing 6 M guanidinium chloride and the above proteinase inhibitors to yield a "G extract. " The polypeptide content of this G extract was examined by discontinuous NaDodSO4/polyacrylamide gel electrophoresis (6) by using a 6.5% (wt/vol) separating gel and a 3% (wt/vol) stacking gel. Analyses also were conducted after incubation of G extract for 4 hr-at 370C with 4 units of highly purified bacterial collagenase (collagenase form III, Advance Biofactures, Lynnbrook, NY) per mg of extract in 50 mM Tris'HCl buffer (pH 7.4) containing 5 mM CaCl2, 2 mM N-ethylmaleimide, and 1 mM phenylmethylsulfonyl fluoride. Treatment of G extract with chymotrypsin (Armour Pharmaceutical, U.K.) was carried out in 0.2 M Tris'HCl buffer (pH 7.4) containing 21 mM CaCl2 for 16 hr at 370C at an enzyme/ substrate ratio of 1:400.
Aggregation Studies. Human blood collected by venipuncture, either from healthy volunteers who had not taken any drugs for at least 1 week or from patients with severe vWF deficiency, was anticoagulated with 1 vol of 3.8% (wt/vol) citrate per 9 vol of blood and was centrifuged at 90 X g for 20 min at 150C to obtain platelet-rich plasma (PRP). Platelet-poor plasma (PPP) was obtained from PRP by centrifugation at 2,000 X g for 20 min at 15'C. In some experiments, normal twice-washed platelets obtained by the method of Patscheke (7) were resuspended in citrated PPP from normal donors or from the patients. The aggregation of platelets was monitored in a Bryston aggregometer at 370C under continuous stirring at 1,100 rpm with 0.4 ml of platelet suspension. The velocity and intensity of the aggregation were determined by measuring the percentage of aggregation 30 and 120 sec, respectively, after the increase in light transmission (corresponding to the aggregation of the platelets) began to be observed.
The ability of the G extract to promote platelet aggregation was compared with that of type III collagen from calf skin prepared according to Fujii and Kuhn (8) . The G extract was suspended in water (1 mg/ml) and was dispersed by sonication (10 sec at 4°C at maximal setting with 0.9-cm-diameter probe in MSE Sonicator). Samples in the range of 1.25-20 ,ug of G extract were added to the platelet suspension (0.4 ml). In control experiments type III collagen was resuspended in water (1 mg/ ml) and was treated as described above. In addition, polymerized type III collagen was prepared as follows. Collagen (0.5 mg) was dissolved in 0.1 M Tris'HCl buffer (pH 7.4), kept at 4°C
Abbreviations: vWF, von Willebrand factor; PRP, platelet-rich plasma; PPP, platelet-poor plasma.
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. composition with very low hydroxyproline, hydroxylysine, and glycine contents, as compared to collagen, but a high content of dicarboxylic amino acid residues, demonstrating an overall composition similar to aortic preparations considered to represent "structure glycoproteins" (13) . When the G extract was treated with highly purified bacterial collagenase no modification of the electrophoresis profile was observed under conditions in which standard preparations oftypes I and III collagen were completely digested. In contrast, under conditions in which collagen was not digested by chymotrypsin, the G extract was reduced to only two low molecular weight peptides, as observed by polyacrylamide gel electrophoresis (not shown). A further property that distinguished the G extract from collagenous macromolecules was its marked insolubility in solutions other than dissociative buffers, such as 6 M urea or 6 M guanidinium chloride. Platelet Aggregation Studies. The ability of the G extract to promote platelet aggregation was examined, but because of its insolubility in mild buffers, the extract was resuspended in water and carefully dispersed by sonication. Under these conditions the G extract was found to be a very potent inducer of platelet aggregation, even when amounts as low as 1.25 Ag were used ( Table 2) . By comparison, type III collagen dispersed in a similar manner was ineffective, even at concentrations 10-to 15-fold higher. However, when type III collagen was first induced to polymerize and to form fibrils, it was found to be ef- fective at concentrations similar to those at which the G extract elicited platelet aggregation, although the G extract always gave rise to a shorter lag phase (Table 2 ).
Platelet Aggregation in the Presence of von Willebrand
Plasma. Another important and distinctive feature of the interaction between blood platelets and G extract is the requirement for plasma factors in the aggregation process. Normal washed platelets in the resuspension buffer described by Patscheke (7) can be aggregated by collagen, to the same extent as in plasma, whereas under these conditions no aggregation, or only a weak aggregation, was observed with the G extract (Table  3 ). This suggested that some component of normal plasma was required to achieve the aggregation. Moreover, the aggregation by the G extract of platelets from patients with severe vWF deficiency was strongly diminished (90-100%), whereas the aggregation induced by type III collagen was not modified, the only difference being a longer lag phase (Table 3 ). The role of plasma factor was confirmed by the fact that twice-washed normal platelets resuspended in plasma derived from these patients also were abnormally aggregated by the G extract. Platelet Aggregation in the Presence of AN51 Antibody. AN51 is an antibody directed against the platelet membrane glycoprotein Tb, which is known to be a receptor of vWF (12) . When normal platelets were incubated 60 sec with this antibody before the addition of the G extract (Table 4) , an inhibition of the aggregation was observed and the degree of inhibition was related to the concentration of antibody. IgG AN51 modified (Table 4) . DISCUSSION Extraction of adult bovine aortic tissue with 6 M guanidinium chloride in the presence of proteinase inhibitors yielded a microfibrillar preparation (G extract) with properties that provide evidence for the occurrence in the vessel wall of a noncollagenous component capable of promoting platelet aggregation. This G extract exhibited biochemical and biological properties different from those observed for collagen. Aortic collagen fibers are very insoluble and were extracted only by pepsinization after reduction and alkylation of the tissue (14) . Although the G extract contained very low amounts of hydroxyproline and traces of hydroxylysine, its amino acid composition was quite different from those observed for collagen (Table 1) and presented the characteristics of acidic glycoproteins.
The treatment of the G extract and of type III collagen with collagenase and chymotrypsin confirmed their nonidentity because G extract was resistant to collagenase in conditions in which type III collagen was digested, but the G extract, unlike the collagen, was completely digested by chymotrypsin treatment. Another difference was their solubility because the G extract was insoluble in 0.5 M acetic acid and needed dissociative buffers to achieve solubilization. G extract and collagen also presented differences in their biological activities. Due to its insolubility, G extract must be carefully dispersed by sonication to be a very potent inducer of platelet aggregation. However, collagen must be polymerized into fibers to be active (15) and accordingly, the sonicated type III collagen was inactive towards platelets (Table 2 ).
An important finding arising from these experiments was the observed role of the vWF in the interaction between blood platelets and the G extract. Thus, the aortic "microfibrillar preparation" was less active or inactive towards twice-washed platelets resuspended in buffer or in plasma from patients with severe vWF deficiency, as compared to resuspension in normal plasma (Table 3) . Similar results have been obtained in studies with microfibrils isolated from human placenta (5). This nonreactivity could explain the decreased platelet adhesion in von Willebrand disease. The possibility that vWF may play a role in vivo in platelet-matrix interactions also was suggested by the longer lag phase in the aggregation of the platelets from these patients when the inducer was collagen (Table 3) . Moreover, platelet aggregation induced by the G extract was inhibited by IgG AN51, a monoclonal antibody to human platelet glycoprotein Ib. The same results have been observed with placental microfibrils and this antibody also inhibited platelet deposition on the collagenase-treated subendothelium of rabbit aorta (12) .
The results obtained in this study suggest that the aortic extract contains noncollagenous material that can react with blood platelets in a manner analogous to that reported in the investigations with a microfibrillar protein preparation from the placenta (5). This interaction requires the presence of vWF and confirms that in the vessel wall the microfibrils represent a thrombogenic structure.
